Navigation Links
The genome of sesame sheds new lights on oil biosynthesis
Date:3/7/2014

Shenzhen, February 27, 2014 - Researchers from Oil Crops Research Institute of the Chinese Academy of Agricultural Sciences, BGI, University of Copenhagen and other institutes have successfully cracked the genome of high oil content crop sesame, providing new lights on the important stages of seed development and oil accumulation, and potential key genes for sesamin production. The joint efforts made sesame become the second Lamiales to be sequenced along with the former published minute genome of Utricularia gibba. The latest study was published online in Genome Biology.

Sesame, Sesamum indicum L., is considered as the queen of oilseeds for its high oil content and quality. It is grown widely in tropical and subtropical areas as an important source of oil and protein. Compared to other eatable oil crops such as soybean, rapeseed, peanut and olive, sesame has innate superiority for its high oil content (~55% of dry seed), and thus is an attractive model for studying lipid biosynthesis. However, currently only limited genomic data of sesame is available.

In this study, researchers presented a high-quality draft genome of the sesame genotype 'Zhongzhi No. 13', an elite cultivar in China been planted over the past ten years. After data process, the assembled sesame genome size is about 337 Mb, with a total of 27,148 genes. The result highlighted the absence of the Toll/interleukin-1 receptor domain in resistance genes, and suggested that this may be a new paradigm in elucidating the interaction of resistance genes along with diseases.

To explore the molecular mechanism of lipid biosynthesis, researchers conducted comparative genomic and transcriptomic analyses and found an expansion on type 1 lipid transfer genes by tandem duplication, a contraction on lipid degradation genes, and the differential expression of essential genes in the triacylglycerol biosynthesis pathway, particularly in the early stage of seed development. Researchers further resequenced 29 sesame accessions from 12 countries to investigate the genetic diversity of lipid-related genes.

Sesamin is an oil-soluble furofuran lignan typically present in sesame seed. Numerous studies on rats and mice have suggested various health benefits of sesamin. This compound is known to promote normalize blood pressure, lower cholesterol, protect the liver, and contribute to weight loss. Sesamin biosynthesis involves two key genes encoding dirigent protein (DIR) and piperitol/sesamin synthase (PSS), respectively. In this study, researchers found that DIR homologues were present in sesame and tomato, but the PSSs are only detected in sesame, indicating the genetic foundation for the sesame-specific product.


'/>"/>

Contact: Jia Liu
liujia@genomics.cn
BGI Shenzhen
Source:Eurekalert

Related biology news :

1. Leading evolutionary scientist to discuss how genome of bacteria has evolved
2. Darwin in the genome
3. Analysis of stickleback genome sequence catches evolution in action
4. Athletic frogs have faster-changing genomes
5. PNAS: Precise molecular surgery in the plant genome
6. BGI and Aspera collaborate on high-speed data exchange to advance genome research
7. Researchers announce GenomeSpace environment to connect genomic tools
8. UC Santa Cruz builds national data center for cancer genome research
9. BGI reports the completed sequence of foxtail millet genome
10. Relative reference: Foxtail millet offers clues for assembling the switchgrass genome
11. Maps of Miscanthus genome offer insight into grass evolution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2016)... NEW YORK , December 22, 2016 ... global provider of secure solutions for the e-Government, Public Safety, HealthCare, ... a subsidiary of SuperCom, has been selected to implement and deploy ... county in Northern California , further expanding its ... ...
(Date:12/19/2016)... BARCELONA , España y TORONTO , 19 ... fusión con Northern Biologics Inc. que permitirá el desarrollo acelerado de ... ensayos clínicos en varios tipos de tumor en 2017, con múltiples ... ... de su clase con objetivo en el factor inhibidor de leucemia ...
(Date:12/16/2016)... global wearable medical device market, in terms of value, is projected ... in 2016, at a CAGR of 18.0% during the forecast period. ... Growth in ... launch of a growing number of smartphone-based healthcare apps compatible with ... increasing focus on physical fitness. Furthermore, growing trend ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... , ... January 19, 2017 , ... FireflySci Inc. is ... rate. The tremendous growth is accounted to two main factors. The first ... the expanding network of vendors supplying FireflySci products all around the world. , 2016 ...
(Date:1/19/2017)... Jan. 18, 2017 BD (Becton, Dickinson and Company) (NYSE: ... that it will host a live webcast of its Annual Meeting ... The webcast can be accessed from the BD ... through Tuesday, January 31, 2017. ... About BD BD is a global medical ...
(Date:1/18/2017)... N.J. , Jan. 18, 2017   Parent ... the fight to end Duchenne muscular dystrophy (Duchenne) ... to the New Jersey Institute of Technology (NJIT) and ... exploration of robotic technology to assist people ... to incorporate NJIT,s technology – an embedded computer, software, ...
(Date:1/18/2017)... ... January 18, 2017 , ... MYOLYN, which ... it has submitted a 510(k) to the FDA, requesting clearance of the MyoCycle ... electrical stimulation (FES) technology. , The submission marks a major milestone for ...
Breaking Biology Technology: